MARKET

ACON

ACON

Aclarion Inc
NASDAQ
3.060
-0.220
-6.71%
After Hours: 3.000 -0.06 -1.96% 18:58 03/27 EDT
OPEN
3.210
PREV CLOSE
3.280
HIGH
3.240
LOW
3.050
VOLUME
26.58K
TURNOVER
--
52 WEEK HIGH
21.32
52 WEEK LOW
2.340
MARKET CAP
8.73M
P/E (TTM)
-0.2249
1D
5D
1M
3M
1Y
5Y
1D
Aclarion Is Maintained at Buy by Ascendiant Capital
Dow Jones · 3d ago
Aclarion Price Target Cut to $7.00/Share From $23.00 by Ascendiant Capital
Dow Jones · 3d ago
Ascendiant Capital Maintains Buy on Aclarion, Lowers Price Target to $7
Benzinga · 3d ago
Echo Lake calls on Aclarion director David Neal to resign
TipRanks · 4d ago
Echo Lake Capital urges Aclarion shareholders to oust director David Neal after 99% stock decline
Reuters · 4d ago
Weekly Report: what happened at ACON last week (0316-0320)?
Weekly Report · 5d ago
Aclarion Adopts One-Year Stockholder Rights Protection Plan
TipRanks · 03/19 20:56
Aclarion adopts 1-year stockholder rights plan with USD 14 exercise price
Reuters · 03/19 20:16
More
About ACON
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The Company has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that Aclarion, in conjunction with spine researchers at University of California San Francisco (UCSF), have demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. After processing the MRS exam data, the Company sends the ordering clinician a report that details how to interpret the results of the MRS exam. The platform used to conduct a NOCISCAN involves a diagnostic report called a Nocigram that identifies discs as painful or not.

Webull offers Aclarion Inc stock information, including NASDAQ: ACON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACON stock methods without spending real money on the virtual paper trading platform.